NIH

Stem cells derived from patients with pulmonary arterial hypertension provide a unique resource for studying the molecular defects that cause the disease and testing potential therapies. Read More

Drugs developed at Vanderbilt could provide a new way to treat schizophrenia in a personalized way. Read More

A combination treatment delivered to the site of fractures may improve bone healing in patients with the genetic disease neurofibromatosis type-1. Read More

Up to 60 percent of patients who receive a stem cell transplant using cells from another donor will develop post-transplant diabetes mellitus, which can increase the rate of complications and death after the procedure. Read More

Vanderbilt University’s Richard Caprioli, Ph.D., is participating in a national, federally funded collaboration to develop an intravaginal ring capable of delivering antiretroviral drugs to women at risk for HIV infection. Read More

Two proteins interact to maintain selenium levels in the brain, and protect neurons from degeneration. Read More

Vanderbilt researchers have identified a new target for blocking breast cancer metastasis. Read More

In some cases, HDL, the "good cholesterol," may not function properly and may actually accelerate atherosclerosis. Read More

Vanderbilt-led research found regular blood transfusion therapy significantly reduces the recurrence of strokes in children with sickle cell anemia who have previously had "silent" strokes. Read More

Endothelial cells residing in the coronary arteries can function as cardiac stem cells to produce new heart muscle tissue, Vanderbilt University investigators have discovered. Read More

Compounds developed at Vanderbilt University may offer a new way to block influenza infection. Read More

Understanding the cellular and molecular responses of the eye to blast injury could guide new treatment development. Read More

Early weight regain after gastric bypass surgery does not reverse metabolic improvements, and the "hunger hormone" ghrelin might indicate who is susceptible to weight regain. Read More

Vanderbilt’s David Penson, M.D., MPH, director of the Center for Surgical Quality and Outcomes Research, has been named to serve as chair of the Health Services Organization and Delivery Study Section in the Center for Scientific Review (CSR) of the National Institutes of Health. He will serve a two-year term. Read More

Inhibition of BMP growth factor signaling reduces breast tumor burden and metastasis. Read More

An enzyme therapy may prevent skeletal abnormalities associated with the genetic disorder neurofibromatosis type-1, Vanderbilt investigators have discovered. Read More

Vanderbilt researchers have found that selenium deficiency may contribute to the racial disparity in lung cancer incidence. Read More

Vanderbilt investigators have constructed a network map that could guide the development of new targeted cancer therapies. Read More

A new brain study has identified the brain mechanisms that underlie our judgment of how severely a person who has harmed another should be punished. Read More

Vanderbilt researchers have discovered that the protein CRADD counteracts inflammatory injury to endothelial cells, which could assist the development of new therapies for inflammatory vascular disorders. Read More